CCM
VCYT icon

Camber Capital Management’s Veracyte VCYT Stock Holding History

Camber Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-910,334
Closed -$4.27M – 53
2015
Q3 		$4.27M Sell
910,334
-316,660
-26% -$3.02M 0.37% 39
2015
Q2 		$13.7M Buy
+1,226,994
New +$12.1M 0.93% 30

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Camber Capital Management's VCYT Position: Q4 2015 in Review

Camber Capital Management sold out of Veracyte (VCYT) in Q4 2015, closing a stake of 910,334 shares — an estimated $4.27M sold.

Camber Capital Management first reported a position in VCYT in Q2 2015 and held it in 2 quarters. The position peaked at $13.7M in Q2 2015. 64 funds tracked by Wall St. Rank hold VCYT as of Q4 2015.

  • Camber Capital Management reported no remaining Veracyte position as of Q4 2015 after selling out during the quarter.
  • Camber Capital Management sold 910,334 Veracyte shares in Q4 2015, an estimated $4.27M.
  • Camber Capital Management first reported a position in Veracyte in Q2 2015 and held it in 2 quarters.
  • Camber Capital Management's Veracyte position peaked at $13.7M in Q2 2015.
  • 64 funds tracked by Wall St. Rank held Veracyte as of Q4 2015.

Based on Camber Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.